Correction: Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway

• Yulin Peng,
• Yan Wang,
• Ning Tang,
• Dongdong Sun,
• Yulong Lan,
• Zhenlong Yu,
• Xinyu Zhao,
• Lei Feng,
• Baojing Zhang,
• Lingling Jin,
• Fabiao Yu,
• Xiaochi Ma,
• Chuanzhu Lv

Affiliations

Yulin Peng

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Yan Wang

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Ning Tang

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Dongdong Sun

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Yulong Lan

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Zhenlong Yu

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Xinyu Zhao

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Lei Feng

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Baojing Zhang

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Lingling Jin

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Fabiao Yu

Emergency Department, The Second Affiliated Hospital of Hainan Medical University

Xiaochi Ma

Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University

Chuanzhu Lv

Emergency Department, The Second Affiliated Hospital of Hainan Medical University